2013 Issues

February 2013 Volume 20 Issue 1

 

Establishing Acceptance Limits for Dissolution Performance Verification of USP Apparatus 1 and 2 Using USP Prednisone Tablets Reference Standard Lot Q0H398

Walter W. Hauck, Chensheng Li, Erika S. Stippler, and William E. Brown
U.S. Pharmacopeial Convention, Rockville, MD, USA

PhEq_bootstrap:Open-Source Software for the Simulation of f2Distribution in Cases of Large Variability in Dissolution Profiles

Aleksander Mendyk, Adam Pacławski, Jakub Szlęk, and Renata Jachowicz
Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University- Medical College, Kraków, Poland

Discriminatory Dissolution Test for Tablets Containing α- and β-Thalidomide Polymorphs

Ana Paula Cappra Silva1, Leonardo Zanchetti Meneghini1, Lisiane Bajerski1, Juliana Poglia Carini1,Silvia Ligório Fialho2, Paulo Mayorga1, and Pedro Eduardo Fröehlich1
1Programade Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
2FUNED- Fundação Ezequiel Dias, R. Conde Pereira Carneiro, Belo Horizonte, Brazil

In Vitro Release Evaluation of Gastroretentive Amoxicillin Floating Tablets Employing a Specific Design of the Flow-Through Cell

Laila H. Emara1, Aya R. Abdou1, Ahmed A. El-Ashmawy1,Rania M. Badr1, Nesrin F. Taha1, and Nadia M. Mursi2
1Industrial Pharmacy Laboratory, Medical and Pharmaceutical Chemistry Department, Division of Pharmaceutical Industries, National Research Centre, Dokki, Giza, Egypt
2Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Egypt

Physicochemical Characterization and Dissolution Study of Ibuprofen Compression-Coated Tablets Using Locust Bean Gum

Negar Bashardoust1,2, J. Josephine Leno Jenita1, and Parvin Zakeri-Milani3
1Department of Pharmaceutics, Dayananda Sagar College of Pharmacy, Kumaraswamy, Layout, Bangalore, Karnataka, India
2Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
3Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

UV Analytical Method Suitability for Investigation of BCS Class 2 Biowaivers: Ibuprofen Case

Noelia L. Gonzalez Vidal1 and M. Esther Gil Alegre2
1Cátedra Control de Calidad de Medicamentos, Departamento de Biología, Bioquímica y Farmacia, Universidad Nacional del Sur, Bahía Blanca, Argentina
2Departamento de Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, España

Comparison of In Vitro Dissolution Tests for Commercially Available Aspirin Tablets

Fawzia Khan, Mingzhong Li, and Walkiria Schlindwein
School of Pharmacy, De Montfort University, the Gateway, Leicester, UK

Tribute to Dirk Barends

Question & Answer Section

Margareth Marques and William Brown
United States Pharmacopeia, Rockville,MD


May 2013 Volume 20 Issue 2

 

Dissolution Testing of a Controlled-Release Capsule Formulation: Challenges and Solutions Using a Semi-Automated Dissolution System

Lili Lo, Xujin Lu, and David Lloyd
Analytical and Bioanalytical Development, Bristol-Myers Squibb, New Brunswick, NJ, USA

In Situ Drug Release Monitoring with a Fiber-Optic System: Overcoming Matrix Interferences Using Derivative Spectrophotometry

Alexis Guillot1,2, Markus Limberger1, Johannes Krämer1, and Claus-Michael Lehr2
1PHAST GmbH, Homburg, Germany
2Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Department DDEL, Saarland University, Saarbrücken, Germany

Effect of a Fiber-Optic Probe on the Dissolution of Salicylic Acid Tablets in USP Apparatus 2

Bing Wang1, Gerard Bredael2, and Piero M. Armenante1
1New Jersey Institute of Technology, Otto H. York Department of Chemical, Biological and Pharmaceutical Engineering, Newark, NJ, USA
2Merck & Co., Inc., Summit, NJ, USA

Evaluation of Automation to Increase Efficiency in the Dissolution Lab

Jonathan Kretz and Kirby Wong-Moon
Analytical R&D, Amgen Inc., Thousand Oaks, CA, USA

A Primer on Automating the Vertical Diffusion Cell (VDC)

Royal Hanson and John Heaney
Hanson Research Corp., Chatsworth, CA, USA

Considerations for Automating the Dissolution Test

G. Bryan Crist
Agilent Technologies, Cary, NC, USA

Survey Results for In Vitro-In Vivo Correlations (IVIVC): Critical Variables for Success

Nikoletta Fotaki1, Vivian Gray2, Filippos Kesisoglou3, Steve Mayock4, Tahseen Mirza5, Alger Salt6, and Arzu Selen7
1Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
2Dissolution Technologies, Hockessin, DE, USA
3Biopharmaceutics, Product Value Enhancement, Pharmaceutical Sciences and Clinical Supply, Merck Sharp & Dohme Corp., West Point, PA, USA
4Collegium Pharmaceutical, Inc., Canton, MA, USA
5Office of Manufacturing and Product Quality / Office of Compliance / CDER, United States Food and Drug Administration, Silver Spring, MD, USA
6GlaxoSmithKline, Product Development Laboratory Automation and Platforms, Research Triangle Park, NC, USA
7Office of New Drug Quality Assessment / CDER, United States Food and Drug Administration, Silver Spring, MD, USA

Meeting Report: AAPS Workshop on Oral Bioperformance and 21st Century Testing

Margareth Marques
United States Pharmacopeia, Rockville, MD, USA

Dissolution Highlights from the 2012 AAPS Annual Meeting in Chicago

Nikoletta Fotaki1, Gregory P. Martin2, and Johannes Krämer3
1University of Bath, UK
2Complectors Consulting, Pottstown, PA, USA
3PHAST, Germany

Question & Answer Section

Margareth Marques and William Brown
United States Pharmacopeia, Rockville,MD


August 2013 Volume 20 Issue 3

 

Rationale for Selection of Dissolution Media: Three Case Studies

Nikoletta Fotaki1, William Brown2, Jianmei Kochling3, Hitesh Chokshi4, Hai Miao5, Kin Tang4, and Vivian Gray6
1University of Bath, Bath, UK
2United States Pharmacopeial Convention, Rockville, MD, USA
3Genzyme, Waltham, MA, USA
4Roche, Nutley, NJ, USA
5Vertex Pharmaceuticals, Cambridge, MA, USA
6V. A. Gray Consulting, Inc., Hockessin, DE, USA

Enhancement in Dissolution Rate of Piroxicam by Two Micronization Techniques

J. Varshosaz, A. Khajavinia, M. Ghasemlu, E. Ataei, K. Golshiri, and I. Khayam
Department of Pharmaceutics, Faculty of Pharmacy and Novel Drug Delivery Systems Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

A Dissolution Test for Finasteride in Immediate-Release Capsules

Olimpia Maria Martins Santos, Ana Laura Araújo Santos, Gislaine Ribeiro Pereira, Rudy Bonfilio, and Magali Benjamim de Araújo
Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Rua Gabriel Monteiro da Silva, Alfenas-MG, Brazil

The Effect of Probe Path Length Calibration on Dissolution Tests Performed with a Fiber-Optic In Situ Dissolution Test System

Pingping Xu, Xinxia Li, Li Li, Yang Liu, Bin Kong, Kun Nie, and Jian Chen
School of Pharmacy, Xinjiang Medical University, Xinjiang, Urumqi, China

Comparison of the Solubility and Dissolution of Drugs in Fasted-State Biorelevant Media (FaSSIF and FaSSIF-V2)

Mathew Leigh, Bastian Kloefer, and Michael Schaich
Biorelevant.com, Capital Business Centre, Croydon, Surrey, United Kingdom

Meeting Report: AAPS Workshop on Dissolution Testing and Bioequivalence

Vivian A. Gray
Dissolution Technologies, Hockessin, DE, USA

Updates on USP Activities Related to Dissolution, Disintegration, and Drug Release

Margareth R. C. Marques and William Brown
U. S. Pharmacopeia, Rockville, MD, USA

Question & Answer Section

Margareth Marques and William Brown
United States Pharmacopeia, Rockville,MD


November 2013 Volume 20 Issue 4

 

Investigation of the Disintegration Behavior of Dietary Supplements in Different Beverages

Jieyu Zuo, Yuan Gao, May Almukainzi, and Raimar Löbenberg
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada

In Vitro Dissolution of Insulin Crystal Polymorphs at Model Conditions Relevant to In Vivo Environment

I. Dimitrov1, F. Hodzhaoglu1, and I. Ivanov2
1Department of Phase Formation, Crystalline and Amorphous Materials, Rostislaw Kaischew Institute of Physical Chemistry, Bulgarian Academy of Sciences, Sofia, Bulgaria
2Department of Biomechanics, Institute of Mechanics, Bulgarian Academy of Sciences, Sofia, Bulgaria

Development and Validation of a Discriminating Dissolution Method for Darifenacin Extended-Release Tablets

Leonardo Z. Meneghini1, Vinícius Bicca1,2, César A. Junqueira1, Andréa I. H. Adams2, Graciela Carlos1, Pedro E. Fröehlich1, and Ana M. Bergold1
1Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul-UFRG, Porto Alegre, RS, Brasil
2Universidade Federal de Santa Maria-UFSM, Centro de Ciências da Saúde, Depto. Farmácia Industrial-Prédio, Santa Maria, RS, Brasil

Comparative Dissolution Studies of Albendazole Oral Suspensions for Veterinary Use

Noelia L. Gonzalez Vidal11, Walter J. Starkloff1, Silvia Bentancor2, Silvina Castro3, Gonzalo Suarez2, and Santiago D. Palma3
1Cátedra Control de Calidad de Medicamentos, Departamento de Biología, Bioquímica y Farmacia, Universidad Nacional del Sur, San Juan, Bahía Blanca, Argentina
2Laboratorio Farmacología, Facultad Veterinaria, Universidad de la República, Montevideo, Uruguay
3UNITEFA-CONICET, Departamento de Farmacia, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, Argentina

Remembering Jim Swon, Industry Pioneer

In Vitro Dissolution Enhancement of Ondansetron by Solid Dispersion in Superdisintegrants

Rajnikant M. Suthar1, Narendra P. Chotai1, Hardik K. Patel1, Sandip R. Patel1, Digesh D. Shah2, and Mukesh B. Jadeja3
1Department of Pharmaceutics and Pharmaceutical Technology, Sardar Patel University, A. R. College of Pharmacy, Vallabh Vidyanagar, Anand, Gujarat, India
2Sanofi Aventis Pharmadeuticals Ltd., Ankaleshwar, Gujarat, India
3Smt. S. M. Shah College of Pharmacy, Mahemdavad, Gujarat, India

Technical Note: Non-Sink Dissolution Media for Identification of Functional Formulation Excipients— The Case of a Precipitation Inhibitor

Maria T. Cruañes, Kimberly Bentz, Wei Xu, and Laura Artino
Pharmaceutical Sciences and Clinical Supply, Merck Research Laboratories, Merck and Co., West Point, PA, USA

CRS Workshop Report: Using an In Vitro-In Vivo Correlation (IVIVC) to Meet Challenges in Global Delivery

Mario A. Gonzalez1 and Vivian A. Gray2
1P'Kinetics International, Inc., Pembroke Pines, FL, USA
2V. A. Gray Consulting, Inc., Hockessin, DE, USA

AAPS Workshop Report on Biorelevant In Vitro Performance Testing of Orally Administered Dosage Forms

Johannes Krämer
PHAST, Germany

Approaches to the Investigation of Dissolution Testing Changes and Failures: AAPS Webinar Summary

Jianmei Kochling
Genzyme, a Sanofi Company, Framingham, MA, USA

Question & Answer Section

Margareth Marques and William Brown
United States Pharmacopeia, Rockville,MD